---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-130803"
form_type: "8-K/A"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:11:16.426735+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Cara Therapeutics files amended 8-K to correct investor presentation for proposed merger with Tvardi Therapeutics

## Summary
- Merger agreement with Tvardi Therapeutics and merger sub was signed on December 17, 2024.
- Asset Purchase Agreement with Vifor Fresenius Medical Care Renal Pharma for disposition of assets was signed on December 17, 2024.
- Stockholder support agreements and lock-up agreements were filed with the SEC on December 17, 2024.
- This amendment corrects formatting errors in the investor presentation originally filed on December 18, 2024.

## SEC filing metadata
- accession: 0001104659-24-130803
- form_type: 8-K/A
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/0001104659-24-130803-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/tm2431662d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-130803
- JSON: https://secwatch.observer/filing/0001104659-24-130803.json
- Plain text: https://secwatch.observer/filing/0001104659-24-130803.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.